Company Filing History:
Years Active: 1977
Title: James W. Eichelberger: Innovator in Enzymatic Reactor Technology
Introduction
James W. Eichelberger is a notable inventor based in Plainfield, NJ (US). He has made significant contributions to the field of enzymatic reactors, particularly in the area of blood clotting factor analysis. His innovative approach has the potential to enhance the accuracy of medical diagnostics.
Latest Patents
Eichelberger holds a patent for a "Method and apparatus for determining deficiencies in enzymatic reactors." This invention relates to the peak value of the first derivative of the optical density time curve, which is associated with individual clotting factor levels, whether deficient or elevated. The relationship is logarithmic for all factors except fibrinogen, for which it is linear. The apparatus and process disclosed in this patent apply this relationship to determine blood clotting factor levels effectively.
Career Highlights
James W. Eichelberger is affiliated with Bio/Data Corporation, where he has been instrumental in advancing technologies related to enzymatic reactors. His work has contributed to the development of more precise diagnostic tools in the medical field.
Collaborations
Eichelberger has collaborated with notable colleagues, including Frederick M. Kent and Michael Sokol. Their combined expertise has fostered innovation and progress in their respective fields.
Conclusion
James W. Eichelberger's contributions to enzymatic reactor technology exemplify the impact of innovative thinking in medical diagnostics. His patent and work at Bio/Data Corporation highlight the importance of advancements in this critical area.